TANG CAPITAL MANAGEMENT LLC Q3 2017 Filing

Filed November 14, 2017

Portfolio Value

$327.5B

Holdings

5

Report Date

Q3 2017

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
HRTXHERON THERAPEUTICS INC
8,643,739$139.6B42.62%
2
—LA JOLLA PHARMACEUTICAL CO
3,440,419$119.7B36.54%
3
—IGNYTA INC
4,763,602$58.8B17.96%
4
BMRNBIOMARIN PHARMACEUTICAL INC
90,215$8.4B2.56%
5
—CYCLACEL PHARMACEUTICALS INC
559,900$1.0B0.31%